What do you monitor?
Curated feeds for your role. Pick your area and get exactly the sources you need.
Compliance & Legal
Legal Research
Court opinions, regulatory guidance, and enforcement actions. AI-summarized.
Financial Compliance
SEC, OCC, FDIC, Fed, FINRA, CFPB, FASB, and state banking regulators. One feed.
Insurance Compliance
State commissioner bulletins, NAIC model laws, and DOI enforcement actions.
Environmental Compliance
EPA enforcement, state environmental agencies, PFAS regulatory updates.
Data Privacy
State AG privacy enforcement, FTC actions, CPPA rulemaking, and HIPAA enforcement.
Tax Compliance
IRS guidance changes and state tax department bulletins.
AML Compliance
FinCEN, OCC, FDIC, Fed, FATF, and banking regulator enforcement.
Labor & Employment
NLRB decisions, EEOC guidance, DOL wage updates, and 50-state labor law changes.
Immigration Law
USCIS policy changes, visa bulletin updates, CBP processing changes.
Industry
Pharma & Life Sciences
FDA warning letters, drug approvals, ICH guidelines, EMA updates, and DEA scheduling.
Energy & Utilities
FERC orders, state PUC decisions, and energy regulatory changes.
Cybersecurity
CISA KEV catalog, ICS-CERT, NSA advisories, NIST CSF, and FedRAMP updates.
Healthcare Compliance
CMS transmittals, OIG work plan, HIPAA enforcement, and Medicaid updates.
Trade & Procurement
Recent changes
US v. Antionne Cherry - Sentencing Appeal
The Fourth Circuit Court of Appeals affirmed the sentence of Antionne Cherry, who appealed his conviction for being a felon in possession of a firearm. The court found that any error in calculating Cherry's sentencing guidelines range was harmless.
FDA Warning Letter to Kare Solutions LLC dba Zappy
The FDA issued a warning letter to Kare Solutions LLC dba Zappy for misbranding compounded drug products, including semaglutide, tirzepatide, and liraglutide. The agency found that Zappy's website made false or misleading claims about these products, suggesting they were FDA-approved or compounded by Zappy when they were not.
FDA Warning Letter to Strut Health, LLC
The FDA issued a warning letter to Strut Health, LLC on February 20, 2026, for misbranding compounded semaglutide and tirzepatide products. The company's website allegedly made false or misleading claims about these drugs, violating the Federal Food, Drug, and Cosmetic Act.
FDA Warning Letter to GenoGenix LLC
The FDA issued a warning letter to GenoGenix LLC for serious deficiencies in drug production practices, including failures to meet conditions for outsourcing facilities and insanitary conditions. The company has ceased production and initiated a voluntary recall of drug products.
FDA Warning Letter to Beta Bionics, Inc.
The FDA issued a warning letter to Beta Bionics, Inc. regarding violations of the Quality System Regulation for their iLet Dosing Decision Software and iLet ACE Pump. The letter details failures in corrective and preventive action procedures, including inadequate analysis of complaints leading to serious adverse health outcomes.
FDA Warning Letter to Diasol, Inc. for Medical Device Violations
The FDA issued a warning letter to Diasol, Inc. for manufacturing unapproved and misbranded medical devices, specifically disinfectants for hemodialysis systems. The company also violated Quality System Regulation requirements. The FDA has requested corrective actions to ensure compliance.
FDA Warning Letter to Yuyao City Boss Vegetable Factory
The FDA issued a warning letter to Yuyao City Boss Vegetable Factory Co. Ltd. for serious violations of food safety regulations, including failure to maintain processing records and fabrication of data. The violations relate to acidified foods intended for export to the United States.
FDA Warning Letter to John Yoder Farm
The FDA issued a warning letter to John Yoder Farm for serious violations of the Shell Egg Regulation (21 CFR Part 118) and the FD&C Act. The farm failed to implement a written Salmonella Enteritidis Prevention Plan and had other insanitary conditions. The FDA is concerned about the compliance status and potential health risks.
FDA Warning Letter to The Father's Table, LLC
The FDA issued a warning letter to The Father's Table, LLC, for serious violations of Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventative Controls for Human Food regulations. The inspection found Listeria monocytogenes in the facility, rendering ready-to-eat food products adulterated.
FDA Warning Letter to Black Sheep Egg Company
The FDA issued a warning letter to Black Sheep Egg Company, LLC, following an inspection that detected Salmonella in environmental samples from their shell egg processing facility. The company is cited for insanitary conditions and violations of the Shell Egg regulation, rendering their products adulterated.
Browse by category
US Federal
973 sources
US State
116 sources
US Courts
122 sources
UK
77 sources
EU
57 sources
Canada
27 sources
Courts & Legal
310 sources
Government & Legislation
257 sources
Banking & Finance
222 sources
Trade & Sanctions
124 sources
Healthcare
122 sources
Labor & Employment
110 sources
Energy
100 sources
Pharma & Drug Safety
84 sources
Environment
83 sources
Securities & Markets
74 sources
Tax
62 sources
Agriculture & Food Safety
61 sources
Data Privacy & Cybersecurity
61 sources
Transportation
56 sources
Insurance
55 sources
Defense & National Security
48 sources
Consumer Protection
39 sources
Telecom & Technology
36 sources
Education
20 sources
Housing
15 sources
Immigration
9 sources
Legal & Courts
1 sources
Browse by agency
CRB
3 sources
EBSA
3 sources
NY Courts
3 sources
KS Courts
3 sources
DOI
3 sources
OR Courts
3 sources
VA
3 sources
PBGC
3 sources
Health Canada
3 sources
SFO
3 sources
Fiscal Service
3 sources
STB
3 sources
HHS OIG
3 sources
AMF France
3 sources
NCSC
3 sources
ASIC
3 sources
FEC
3 sources
State Consumer Protection
3 sources
ACPR
3 sources
AL Courts
3 sources
Get alerts when regulations change
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.